Literature DB >> 19211667

Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA.

Joachim H Ix1, Ian H De Boer, Carmen A Peralta, Kathryn L Adeney, Daniel A Duprez, Nancy S Jenny, David S Siscovick, Bryan R Kestenbaum.   

Abstract

BACKGROUND AND OBJECTIVES: Higher phosphorus levels are associated with cardiovascular disease (CVD) events and mortality. Whether vascular stiffness may be responsible is unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study examined the cross-sectional associations of serum phosphorus with ankle brachial index (ABI), pulse pressure, and large and small artery elasticity by radial artery waveform analysis among 1370 individuals (440 with moderate chronic kidney disease) who did not have clinical CVD and participated in the Multi-Ethnic Study of Atherosclerosis.
RESULTS: Fifty-nine (4%) individuals had high ABI (>1.30), a marker of peripheral arterial stiffness. Participants with phosphorus levels >4 mg/dl had greater than four-fold risk for high ABI compared with participants with phosphate levels <3 mg/dl (relative risk 4.6; 95% confidence interval 1.6 to 13.2; P = 0.01) after adjustment for demographics, traditional CVD risk factors, and kidney function. Higher phosphorus levels were also associated with greater pulse pressure and lesser large and small artery elasticity in unadjusted models, but these associations were attenuated after adjustment.
CONCLUSIONS: Higher phosphorus levels are strongly associated with high ABI but not pulse pressure or large or small artery elasticity. If confirmed in future studies, then the association of higher phosphorus concentrations with CVD events may be partially mediated through peripheral arterial stiffness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211667      PMCID: PMC2653665          DOI: 10.2215/CJN.04100808

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  31 in total

1.  Role of the extracellular matrix in age-related modifications of the rat aorta. Ultrastructural, morphometric, and enzymatic evaluations.

Authors:  C Fornieri; D Quaglino; G Mori
Journal:  Arterioscler Thromb       Date:  1992-09

2.  Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus.

Authors:  S Lehto; L Niskanen; M Suhonen; T Rönnemaa; M Laakso
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-08       Impact factor: 8.311

3.  Age-related changes in amounts and concentrations of collagen and elastin in normotensive human thoracic aorta.

Authors:  M A Cattell; J C Anderson; P S Hasleton
Journal:  Clin Chim Acta       Date:  1996-02-09       Impact factor: 3.786

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  The aortic tunica media in aging rats.

Authors:  W J Cliff
Journal:  Exp Mol Pathol       Date:  1970-10       Impact factor: 3.362

6.  Medial arterial calcification and its association with mortality and complications of diabetes.

Authors:  J E Everhart; D J Pettitt; W C Knowler; F A Rose; P H Bennett
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

7.  A comparison of Doppler ankle pressures and skin perfusion pressure in subjects with and without diabetes.

Authors:  F G Quigley; I B Faris; H J Duncan
Journal:  Clin Physiol       Date:  1991-01

8.  Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study.

Authors:  Helaine E Resnick; Robert S Lindsay; Mary McGrae McDermott; Richard B Devereux; Kristina L Jones; Richard R Fabsitz; Barbara V Howard
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

9.  Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects.

Authors:  M J Young; J E Adams; G F Anderson; A J Boulton; P R Cavanagh
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

10.  Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

Authors:  Geoffrey A Block; Preston S Klassen; J Michael Lazarus; Norma Ofsthun; Edmund G Lowrie; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

View more
  70 in total

1.  Associations of estradiol and testosterone with serum phosphorus in older men: the Osteoporotic Fractures in Men study.

Authors:  Jerry Meng; Claes Ohlsson; Gail A Laughlin; Michel Chonchol; Christina L Wassel; Osten Ljunggren; Magnus K Karlsson; Dan Mellstrom; Eric S Orwoll; Elizabeth Barrett-Connor; Joachim H Ix
Journal:  Kidney Int       Date:  2010-06-09       Impact factor: 10.612

2.  Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.

Authors:  Jessica Houston; Kelsey Smith; Tamara Isakova; Nicole Sowden; Myles Wolf; Orlando M Gutiérrez
Journal:  J Ren Nutr       Date:  2012-03-09       Impact factor: 3.655

Review 3.  The role of phosphorus in the development and progression of vascular calcification.

Authors:  Jessica Kendrick; Michel Chonchol
Journal:  Am J Kidney Dis       Date:  2011-09-28       Impact factor: 8.860

4.  The association of bone density and calcified atherosclerosis is stronger in women without dyslipidemia: the multi-ethnic study of atherosclerosis.

Authors:  Nicole E Jensky; Joseph A Hyder; Matthew A Allison; Nathan Wong; Victor Aboyans; Roger S Blumenthal; Pamela Schreiner; J Jeffrey Carr; Christina L Wassel; Joachim H Ix; Michael H Criqui
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

Review 5.  Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.

Authors:  Julia J Scialla; Myles Wolf
Journal:  Nat Rev Nephrol       Date:  2014-04-01       Impact factor: 28.314

6.  Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.

Authors:  Darbie Maccubbin; Diane Tipping; Olga Kuznetsova; William A Hanlon; Andrew G Bostom
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

7.  Elevated serum phosphate levels are associated with decreased amputation-free survival after interventions for critical limb ischemia.

Authors:  Sara L Zettervall; Peter A Soden; Klaas H J Ultee; Crystal Seldon; Jinhee Oh; Kevin McGann; Marc L Schermerhorn; Raul J Guzman
Journal:  J Vasc Surg       Date:  2016-09-22       Impact factor: 4.268

8.  Dietary phosphorus, blood pressure, and incidence of hypertension in the atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosis.

Authors:  Alvaro Alonso; Jennifer A Nettleton; Joachim H Ix; Ian H de Boer; Aaron R Folsom; Aurelian Bidulescu; Bryan R Kestenbaum; Lloyd E Chambless; David R Jacobs
Journal:  Hypertension       Date:  2010-01-18       Impact factor: 10.190

9.  Serum Phosphate and Microvascular Function in a Population-Based Cohort.

Authors:  Charles Ginsberg; Alfons J H M Houben; Rakesh Malhotra; Tos T J M Berendschot; Pieter C Dagnelie; Jeroen P Kooman; Caroll A Webers; Coen D A Stehouwer; Joachim H Ix
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-20       Impact factor: 8.237

10.  24-hour urine phosphorus excretion and mortality and cardiovascular events.

Authors:  Heather L Palomino; Dena E Rifkin; Cheryl Anderson; Michael H Criqui; Mary A Whooley; Joachim H Ix
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.